Supreme Court to decide Bayer’s bid to block thousands of Roundup lawsuits

The Supreme Court agreed to hear Bayer’s appeal aimed at blocking thousands of state lawsuits alleging the Roundup weedkiller causes cancer, weighing whether EPA approval without a cancer warning should defeat the claims. The Trump administration backs Bayer, reversing the Biden administration, while EPA officials say glyphosate is unlikely to be carcinogenic when used as directed. Bayer has set aside about $16 billion to settle claims and has pushed for state-level immunity laws, with Georgia and North Dakota enacting such measures. A Missouri case involving non-Hodgkin’s lymphoma is part of the docket, and Bayer faces roughly 181,000 claims overall. A 2024 appellate ruling favored Bayer, and the company has signaled it could remove glyphosate from U.S. residential markets but would retain it for agriculture; timing for arguments remains uncertain.